Target Price | $5.80 |
Price | $1.92 |
Potential |
202.08%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Prelude Therapeutics Inc 2025 .
The average Prelude Therapeutics Inc target price is $5.80.
This is
202.08%
register free of charge
$10.00
420.83%
register free of charge
$3.00
56.25%
register free of charge
|
|
A rating was issued by 5 analysts: 3 Analysts recommend Prelude Therapeutics Inc to buy, 0 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Prelude Therapeutics Inc stock has an average upside potential 2025 of
202.08%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.02 | -1.86 |
17.21% | 7.92% | |
P/E | negative |
2 Analysts have issued a Prelude Therapeutics Inc forecast for earnings per share. The average Prelude Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Prelude Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.